Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0BK6B
|
||||
Former ID |
DNC003901
|
||||
Drug Name |
CI-930
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Discontinued in Phase 2 | [544562] | ||
Structure |
Download2D MOL |
||||
Formula |
C14H14N4O
|
||||
Canonical SMILES |
CC1CC(=O)NN=C1C2=CC=C(C=C2)N3C=CN=C3
|
||||
InChI |
1S/C14H14N4O/c1-10-8-13(19)16-17-14(10)11-2-4-12(5-3-11)18-7-6-15-9-18/h2-7,9-10H,8H2,1H3,(H,16,19)
|
||||
InChIKey |
AEZZPAQOEUQNBB-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | CGMP-inhibited 3',5'-cyclic phosphodiesterase A | Target Info | Inhibitor | [533015] | |
References | |||||
Ref 533015 | J Med Chem. 1989 Feb;32(2):342-50.Cardiotonic agents. 9. Synthesis and biological evaluation of a series of (E)-4,5-dihydro-6-[2-[4-(1H-imidazol-1-yl)phenyl]ethenyl]-3 (2H)-pyridazinones: a novel class of compounds with positive inotropic, antithrombotic, and vasodilatory activities for the treatment of congestive heart failure. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.